Metabolic, circulatory and respiratory effects of a new sympathomimetic beta-receptor-stimulating agent, terbutaline, compared with those of orciprenaline.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001993:Bronchodilator Agents / Q000494:pharmacology*; D002245:Carbon Dioxide / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005990:Glycerol / Q000097:blood; D006400:Hematocrit; D006439:Hemodynamics / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D009921:Metaproterenol / Q000494:pharmacology; D008722:Methods; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D010627:Phenethylamines / Q000494:pharmacology*; D012118:Resorcinols / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology*
D000318:Adrenergic beta-Agonists; D000605:Amino Alcohols; D001786:Blood Glucose; D001993:Bronchodilator Agents; D005230:Fatty Acids, Nonesterified; D010627:Phenethylamines; D012118:Resorcinols; D013566:Sympathomimetics; D002245:Carbon Dioxide; D009921:Metaproterenol; D005990:Glycerol; D010100:Oxygen